Erratum: Gene expression profiling of pre-eclamptic placentae by RNA sequencing (Scientific Reports (2015) 5 (14107) DOI: 10.1038/srep14107);Gene expression profiling of pre-eclamptic placentae by RNA sequencing

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Kaartokallio, Tea ^a   Cervera, Alejandra ^a   Kyllönen, Anjuska ^a   Laivuori, Krista ^a,b   Kere, Juha ^a,b,c   Laivuori, Hannele ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b FOLKHÄLSAN INSTITUTE OF GENETICS   (Finland)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MESSENGER RNA; TRANSCRIPTOME;

ADULT; FEMALE; GENE EXPRESSION PROFILING; GENETICS; HUMAN; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; PATHOLOGY; PLACENTA; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PREGNANCY; SEQUENCE ANALYSIS;

ADULT; BASE SEQUENCE; BIOMARKERS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MICROARRAY ANALYSIS; PLACENTA; POLYMERASE CHAIN REACTION; PRE-ECLAMPSIA; PREGNANCY; RNA, MESSENGER; SEQUENCE ANALYSIS, RNA; TRANSCRIPTOME;

EID: 84942080019     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep17245     Document Type: Erratum

References (46)

1. Roberts, C. L., Algert, C. S., Morris, J. M., Ford, J. B. & Henderson-Smart, D. J. Hypertensive disorders in pregnancy: a populationbased study. Med. J. Aust. 182, 332-335 (2005).
2. Hernandez-Diaz, S., Toh, S. & Cnattingius, S. Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study. BMJ 338, b2255 (2009).
3. World Health Organization. World Health Report 2005: Make Every Mother and Child Count. (2005). World Health Organization, Geneva, Switzerland.
4. Myatt, L., et al. Strategy for standardization of preeclampsia research study design. Hypertension 63, 1293-1301 (2014).
5. Leavey, K., Bainbridge, S. A. & Cox, B. J. Large scale aggregate microarray analysis reveals three distinct molecular subclasses of human preeclampsia. PLoS One 10, e0116508 (2015).
6. Oudejans, C. B., van Dijk, M., Oosterkamp, M., Lachmeijer, A. & Blankenstein, M. A. Genetics of preeclampsia: paradigm shifts. Hum. Genet. 120, 607-612 (2007).
7. Brosens, I. A., Robertson, W. B. & Dixon, H. G. The role of the spiral arteries in the pathogenesis of preeclampsia. Obstet. Gynecol. Annu. 1, 177-191 (1972).
8. Salafia, C. M., Pezzullo, J. C., Ghidini, A., Lopez-Zeno, J. A. & Whittington, S. S. Clinical correlations of patterns of placental pathology in preterm pre-eclampsia. Placenta 19, 67-72 (1998).
9. Meekins, J. W., Pijnenborg, R., Hanssens, M., McFadyen, I. R. & van Asshe, A. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies. Br. J. Obstet. Gynaecol. 101, 669-674 (1994).
10. Hutchinson, E. S., et al. Utero-placental haemodynamics in the pathogenesis of pre-eclampsia. Placenta 30, 634-641 (2009).
11. Myatt, L., et al. The utility of uterine artery Doppler velocimetry in prediction of preeclampsia in a low-risk population. Obstet. Gynecol. 120, 815-822 (2012).
12. Sweeney, M., Wareing, M., Mills, T. A., Baker, P. N. & Taggart, M. J. Characterisation of tone oscillations in placental and myometrial arteries from normal pregnancies and those complicated by pre-eclampsia and growth restriction. Placenta 29, 356-365 (2008).
13. Knight, M., Redman, C. W., Linton, E. A. & Sargent, I. L. Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-eclamptic pregnancies. Br. J. Obstet. Gynaecol. 105, 632-640 (1998).
14. Goswami, D., et al. Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-eclampsia, but not normotensive intrauterine growth restriction. Placenta 27, 56-61 (2006).
15. Maynard, S. E., et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 111, 649-658 (2003).
16. Levine, R. J., et al. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 350, 672-683 (2004).
17. Redman, C. W. & Sargent, I. L. Latest advances in understanding preeclampsia. Science 308, 1592-1594 (2005).
18. Shen, F., et al. Trophoblast debris extruded from preeclamptic placentae activates endothelial cells: a mechanism by which the placenta communicates with the maternal endothelium. Placenta 35, 839-847 (2014).
19. Kleinrouweler, C. E., et al. Differentially expressed genes in the pre-eclamptic placenta: a systematic review and meta-analysis. PLoS One 8, e68991 (2013).
20. Vaiman, D., Calicchio, R. & Miralles, F. Landscape of transcriptional deregulations in the preeclamptic placenta. PLoS One 8, e65498 (2013).
21. Louwen, F., Muschol-Steinmetz, C., Reinhard, J., Reitter, A. & Yuan, J. A lesson for cancer research: placental microarray gene analysis in preeclampsia. Oncotarget 3, 759-773 (2012).
22. Xu, X., et al. Parallel comparison of Illumina RNA-Seq and Affymetrix microarray platforms on transcriptomic profiles generated from 5-aza-deoxy-cytidine treated HT-29 colon cancer cells and simulated datasets. BMC Bioinformatics 14 Suppl 9, S1-2105- 14-S9-S1. Epub 2013 Jun 28 (2013).
23. Bradford, J. R., et al. A comparison of massively parallel nucleotide sequencing with oligonucleotide microarrays for global transcription profiling. BMC Genomics 11, 282-2164-11-282 (2010).
24. Perkins, J. R., et al. A comparison of RNA-seq and exon arrays for whole genome transcription profiling of the L5 spinal nerve transection model of neuropathic pain in the rat. Mol. Pain 10, 7-8069-10-7 (2014).
25. Zhao, S., Fung-Leung, W. P., Bittner, A., Ngo, K. & Liu, X. Comparison of RNA-Seq and microarray in transcriptome profiling of activated T cells. PLoS One 9, e78644 (2014).
26. Staff, A. C., Johnsen, G. M., Dechend, R. & Redman, C. W. Preeclampsia and uteroplacental acute atherosis: immune and inflammatory factors. J. Reprod. Immunol. 101-102, 120-126 (2014).
27. Inagaki, A., et al. Upregulation of HtrA4 in the placentas of patients with severe pre-eclampsia. Placenta 33, 919-926 (2012).
28. Fajardy, I., et al. Time course analysis of RNA stability in human placenta. BMC Mol. Biol. 10, 21-2199-10-21 (2009).
29. Oudejans, C. B. Maternal plasma RNA sequencing. Clin. Biochem. S0009-9120(15), 00081-8 (2015). doi: 10.1016/j. clinbiochem.2015.03.004.
30. Kaartokallio, T., et al. Microsatellite polymorphism in the heme oxygenase-1 promoter is associated with nonsevere and late-onset preeclampsia. Hypertension 64, 172-177 (2014).
31. ACOG Committee on Obstetric Practice. Practice bulletin #33: diagnosis and management of preeclampsia and eclampsia. Obstetrics & Gynecology 99, 159-167 (2002).
32. Pihkala, J., Hakala, T., Voutilainen, P. & Raivio, K. Characteristic of recent fetal growth curves in Finland. Duodecim 105, 1540-1546 (1989).
33. Kallio, M. A., et al. Chipster: user-friendly analysis software for microarray and other high-throughput data. BMC Genomics 12, 507-2164-12-507 (2011).
34. Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114-2120 (2014).
35. Trapnell, C., Pachter, L. & Salzberg, S. L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25, 1105-1111 (2009).
36. Li, H., et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078-2079 (2009).
37. Anders, S., Pyl, P. T. & Huber, W. HTSeq-a Python framework to work with high-throughput sequencing data. Bioinformatics 31 (2), 166-9 (2014).
38. Trapnell, C., et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28, 511-515 (2010).
39. Goff, L., Trapnell, C. & Kelley, D. cummeRbund: Analysis, exploration, manipulation, and visualization of Cufflinks highthroughput sequencing data (2012). Latest version available at: http://www.bioconductor.org/packages/release/bioc/manuals/ cummeRbund/man/cummeRbund.pdf. Date of access: 19/03/2015.
40. Subramanian, A., et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545-15550 (2005).
41. Mootha, V. K., et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267-273 (2003).
42. Vandesompele, J., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3, RESEARCH0034 (2002).
43. Andersen, C. L., Jensen, J. L. & Orntoft, T. F. Normalization of real-time quantitative reverse transcription-PCR data: a modelbased variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res. 64, 5245-5250 (2004).
44. Ramakers, C., Ruijter, J. M., Deprez, R. H. & Moorman, A. F. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neurosci. Lett. 339, 62-66 (2003).
45. Ruijter, J. M., et al. Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data. Nucleic Acids Res. 37, e45 (2009).
46. Pabinger, S., et al. QPCR: Application for real-time PCR data management and analysis. BMC Bioinformatics 10, 268-2105-10-268 (2009).